# Study of [11C]CPPC to Assess the Safety and Tolerability in Patients With ALS

> **NCT04749433** · PHASE1 · TERMINATED · sponsor: **Johns Hopkins University** · enrollment: 4 (actual)

## Conditions studied

- Amyotrophic Lateral Sclerosis

## Interventions

- **DRUG:** [11C]CPPC Injection

## Key facts

- **NCT ID:** NCT04749433
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-09-01
- **Primary completion:** 2023-03-30
- **Final completion:** 2023-03-30
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** study stopped to enhance protocol and resume under different sponsor
- **Last updated:** 2024-10-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04749433

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04749433, "Study of [11C]CPPC to Assess the Safety and Tolerability in Patients With ALS". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04749433. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*